Concourse Financial Group Securities, Inc. Krystal Biotech, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

29 transactions

Quarter	Operation	Price Per share
Q2 2025 Aug 12, 2025	BUY	$123.36 - $181.0 $0 - $0
Q1 2025 May 14, 2025	BUY	$142.64 - $194.44 $0 - $0
Q4 2024 Feb 13, 2025	BUY	$156.64 - $199.61 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$174.7 - $213.66 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$153.12 - $183.64 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$108.01 - $179.35 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$96.0 - $128.29 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$108.51 - $130.22 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$108.51 - $130.22 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$78.48 - $130.32 $0 - $0
Q1 2023 May 15, 2023	BUY	$72.39 - $84.27 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$63.14 - $79.9 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$64.85 - $82.4 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$48.93 - $73.47 $0 - $0
Q1 2022 May 09, 2022	BUY	$51.99 - $72.11 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$39.81 - $88.24 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$52.01 - $71.77 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$62.14 - $81.82 $0 - $0
Q1 2021 May 13, 2021	BUY	$59.42 - $85.46 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$40.64 - $61.38 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$37.76 - $48.49 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$37.03 - $60.0 $0 - $0
Q1 2020 May 13, 2020	BUY	$35.02 - $65.64 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$33.17 - $65.23 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$34.72 - $51.3 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$27.2 - $41.2 $0 - $0
Q1 2019 May 15, 2019	BUY	$19.86 - $32.9 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$15.03 - $25.38 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$14.43 - $21.0 $0 - $0

Others Institutions Holding KRYS

# of Institutions

322

Shares Held

24.2M

Call Options Held

400K

Put Options Held

563K

Black Rock Inc. New York, NY

3.95M
Shares

$794 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

2.79M
Shares

$562 Million
0.01% of portfolio
Avoro Capital Advisors LLC New York, NY

2.66M
Shares

$535 Million
6.67% of portfolio
State Street Corp Boston, MA

1.36M
Shares

$273 Million
0.01% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

923K
Shares

$186 Million
9.83% of portfolio

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $5.16B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account